Donowitz M, Wicks J, Battisti L, Pike G, DeLellis R
Gastroenterology. 1984 Sep;87(3):503-12.
The mechanism of action of Senokot, a widely used laxative, has not been established. Senokot was given orally to rats 8-14 h before intestinal water and electrolyte transport were studied. Senokot significantly decreased colonic and jejunal water absorption measured in vivo by the single-pass perfusion technique. The Senokot changes were not associated with changes in jejunal or colonic histology or adenylate cyclase activity or colonic cyclic adenosine monophosphate content. Senokot also altered active electrolyte transport in rat descending colon as measured by the Ussing chamber-voltage clamp technique. These changes consisted of an increase in short-circuit current and a decrease in active Na and Cl transport that was due to a decrease in the mucosal-to-serosal fluxes. The changes in active electrolyte transport were dependent on Ca++ in the serosal but not the mucosal bathing solution. In contrast, addition of 10(-4) M verapamil to the serosal surface did not alter the Senokot effect. In spite of a dependence on serosal Ca++, Senokot did not alter 45Ca++ entry across the colonic serosal surface. The phospholipase A2 inhibitor quinacrine (10(-4) M) also did not alter the effect of Senokot on colonic Na and Cl transport. Senokot alters active colonic Na and Cl transport via a presently unknown mechanism that is dependent on serosal Ca++.
常用泻药塞纳科(Senokot)的作用机制尚未明确。在研究肠道水和电解质转运前8 - 14小时,给大鼠口服塞纳科。采用单通道灌注技术在体内测量发现,塞纳科显著降低了结肠和空肠的水吸收。塞纳科引起的这些变化与空肠或结肠组织学、腺苷酸环化酶活性或结肠环磷酸腺苷含量的变化无关。通过尤斯室电压钳技术测量发现,塞纳科还改变了大鼠降结肠的主动电解质转运。这些变化包括短路电流增加以及由于黏膜到浆膜通量减少导致的主动钠和氯转运减少。主动电解质转运的变化取决于浆膜浴液中的Ca++,而不是黏膜浴液中的Ca++。相比之下,在浆膜表面添加10(-4) M维拉帕米并不会改变塞纳科的作用效果。尽管依赖浆膜Ca++,塞纳科并没有改变45Ca++跨结肠浆膜表面的内流。磷脂酶A2抑制剂奎纳克林(10(-4) M)也不会改变塞纳科对结肠钠和氯转运的作用效果。塞纳科通过一种目前未知的机制改变结肠主动钠和氯转运,该机制依赖于浆膜Ca++。